Heartflow (NASDAQ:HTFL) Trading Down 7.8% – Should You Sell?

Heartflow, Inc. (NASDAQ:HTFL)’s share price fell 7.8% during trading on Monday . The company traded as low as $27.45 and last traded at $27.55. 804,157 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 849,217 shares. The stock had previously closed at $29.87.

Wall Street Analyst Weigh In

HTFL has been the subject of several research reports. Canaccord Genuity Group lifted their price objective on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Wells Fargo & Company began coverage on Heartflow in a research note on Wednesday, January 28th. They issued an “overweight” rating and a $38.00 target price for the company. Stifel Nicolaus increased their target price on Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Five analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Heartflow has a consensus rating of “Moderate Buy” and an average price target of $38.50.

Heartflow Stock Performance

The business has a fifty day simple moving average of $30.71. The firm has a market capitalization of $2.45 billion and a PE ratio of -15.90.

Insider Activity at Heartflow

In related news, Director Jeffrey C. Lightcap acquired 40,000 shares of Heartflow stock in a transaction that occurred on Tuesday, December 16th. The stock was acquired at an average price of $26.34 per share, with a total value of $1,053,600.00. Following the completion of the acquisition, the director directly owned 40,000 shares of the company’s stock, valued at $1,053,600. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in HTFL. TFC Financial Management Inc. purchased a new stake in shares of Heartflow in the 3rd quarter valued at approximately $40,000. Emerald Mutual Fund Advisers Trust bought a new position in Heartflow during the third quarter valued at approximately $4,418,000. TrueMark Investments LLC bought a new stake in Heartflow in the third quarter worth $918,000. Baillie Gifford & Co. acquired a new stake in shares of Heartflow in the third quarter worth about $101,182,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Heartflow in the 3rd quarter valued at approximately $234,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.